Skip to content

Care Property Invest stock

CPINV.BRBRU

Care Property Invest S.A., Real EstateISIN BE0974273055

$14.24▼ $0.04 (−0.3%)Closing price of 12 Nov 2026

65Score 65 out of 100, Neutral

Turn on early warning

Price and trend

61 / 100

Price history

+10% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 1.8% above it.

Trend change

Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 66).

Distance to the high

The price is 8.0% below its 52-week high. Largest decline in 20 years: 67% (February 2020 to December 2025).

Chart figures for advanced users
SMA 50$13.74
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$13.99
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)66
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$11.91
The lowest closing price of the last twelve months.
Resistance$15.49
The highest closing price of the last twelve months.
Market cap
$603.96M
Div. yield
6.71%
12 months
6.1
says little for REITs
10.1
on earnings for the next twelve months ($1.41 per share)
Fair value
$22.59

Snapshot

Computed from the data by fixed rules, no AI

  • Care Property Invest S.A. belongs to the REIT (Healthcare Facilities) industry (Belgium) and, with a market value of $602.08M, is number 15 of 18 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $82.15M (up 4.3% year on year) and earnings of $65.83M (up 129.8%).
  • For fiscal 2026, analysts expect on average revenue of $90.87M (up 10.6%) and adjusted earnings per share of $1.37.
Show more
  • MEQIRI Score 65 out of 100 (Neutral): rank 37 of 327 in Real Estate, median 55.
  • The P/E is 6.1 (REIT (Healthcare Facilities) median 14.5, own median of recent years 17).
  • For real estate investment trusts (REITs) what counts is funds from operations (FFO and AFFO). The P/E and the payout ratio of earnings say little here, because depreciation on properties depresses earnings.
  • Our model puts fair value at $22.59, with the price 37% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • High marginNet margin 95.8% over the last 12 months, REIT (Healthcare Facilities) median 6.6%.Profitability 68
  • Modestly valuedP/E 6.1, REIT (Healthcare Facilities) median 14.5, own median 17.Valuation 96
  • Below fair valuePrice 37% below the fair value of $22.59.Valuation 96

Weaknesses

  • DilutionShare count up 51% since 2020.Capital allocation 29
65/ 100
MEQIRI Score
Neutral

Its standout strengths are valuation and growth, while capital allocation holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)50%
ROIC (12 months)6.7%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What lowers it

  • calm price action

Valuation

Valuation signal

Significantly undervalued
Price
$14.29
Fair value
$22.59
Gap to fair value
−37%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $18.82 and expensive above $28.24 (uncertainty low, based on the price swings of the past year).

The two parts of the fair value come to $28.39 (cash-flow model) and $16.78 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 7.7%. At 8.7% the fair value would be $20.22, at 6.7% it would be $26.15.

Valuation metrics

no data
11.3
Fair value (model)
$22.59
Industry part $16.78 (operating cash flow × 14.5)

Half from the cash-flow model, half from operating cash flow per share times the median price to cash flow of the REIT industry (14.5). For the fair value, FFO only counts when it is in line with operating cash flow. That is not the case here, for example because the REIT carries its properties at market value, records little depreciation or a gain on sale sits in earnings. The cash-flow model uses AFFO: operating cash flow less maintenance, estimated at 4% of revenue. New construction and acquisitions do not count as running costs there.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

18 years

In the twelve months to 30 Sep 2026, revenue rose 9.6% on the twelve months before. Revenue has grown strongly since 2008, at around 15% per year.

Margins

18 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 97%, operating 95%, net 80%. Last 12 months: net 96%.

Debt & balance sheet

latest quarter
0.92
4.2x
0.97
Cash & equivalents
$2.2M

Moderate debt, and interest is adequately covered.

Earnings

Next earnings
3 Mar 2027in 111 days
Last reported
4 Nov 2026EPS reported $0.99

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20265 analysts
Earnings per share
$1.370.0%
Revenue
$90.87M0.0%
Fiscal 20275 analysts
Earnings per share
$1.420.0%
Revenue
$93.14M0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

What happened at Care Property Invest

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

327 rated companies in Real Estate

Rank 37 of 327
37/ 327
This company
65
Sector median
55

Categories against the sector median

ProfitabilityMedian of 327 companies68 (median 57)11 above the median
GrowthMedian of 327 companies77 (median 55)22 above the median
FundamentalsMedian of 327 companies65 (median 62)3 above the median
ValuationMedian of 315 companies with a value96 (median 68)28 above the median
StabilityMedian of 327 companies62 (median 56)6 above the median
Capital allocationMedian of 327 companies29 (median 32)3 below the median
Technical analysisMedian of 327 companies61 (median 59)2 above the median
MomentumMedian of 327 companies62 (median 51)11 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in REIT (Healthcare Facilities)

The next larger and next smaller companies by market value

All 18 REIT (Healthcare Facilities) stocks

ETFs that hold Care Property Invest

Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 2 May 2025)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy